North American Vaccine (NVX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine (NVX)

NVX 1.035

-5.5%

Dec 30 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kech who wrote (24)	1/24/1997 12:31:00 PM
From: Don W Stone	of 35

Tom: By the time Chiron has a DTaP product,NVX will be marketing a new DTaP-IPV vaccine so I don't look on Chiron as being any threat. As to SKB it is anybodies guess as to what is going on with their DTaP vaccine. they have some real problems that were disclosed at their Adv Comm. Mtg back in July. I don' tthink they will ever get approval to use it for the 4th and 5th shot. As to price pressure later on. NVX has a state of the art manufacturing facility, that plus the fact that their vaccine is the only moncomponent vaccine makes them for sure the low cost producer. The market in any event is plenty big enough t support several suppliers and NVX being the only pure play makes things very attractive. :-}

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next